These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 1307535

  • 1. Dapsone in cutaneous lesions of SLE: an open study.
    Singh YN, Adya CM, Verma KK, Kumar A, Malaviya AN.
    J Assoc Physicians India; 1992 Nov; 40(11):735-6. PubMed ID: 1307535
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA, Mbuagbaw J, Burge SM.
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus.
    Bezerra EL, Vilar MJ, da Trindade Neto PB, Sato EI.
    Arthritis Rheum; 2005 Oct; 52(10):3073-8. PubMed ID: 16200586
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bullous systemic lupus erythematosus responding to dapsone.
    Ludgate MW, Greig DE.
    Australas J Dermatol; 2008 May; 49(2):91-3. PubMed ID: 18412808
    [Abstract] [Full Text] [Related]

  • 6. [Dapsone for chronic skin lesions in 3 children suffering from Henoch-Schönlein vasculitis].
    Mazille N, Lipsker D, Fischbach M.
    Arch Pediatr; 2011 Nov; 18(11):1201-4. PubMed ID: 21963373
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Dermatologic manifestations in lupus erythematosus].
    Francès C, Barète S, Piette JC.
    Rev Med Interne; 2008 Sep; 29(9):701-9. PubMed ID: 18562046
    [Abstract] [Full Text] [Related]

  • 10. Bullous systemic erythematosus. A case report.
    Aboobaker J, Ramsaroop R, Abramowitz I, Naran AD.
    S Afr Med J; 1986 Jan 04; 69(1):49-51. PubMed ID: 3510460
    [Abstract] [Full Text] [Related]

  • 11. Bullous systemic lupus erythematosus with antiphospholipid syndrome.
    Kacalak-Rzepka A, Zaluga E, Maleszka R, Królicki A, Klimowicz A.
    J Eur Acad Dermatol Venereol; 2004 Jul 04; 18(4):490-4. PubMed ID: 15196171
    [Abstract] [Full Text] [Related]

  • 12. Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy.
    Hall RP, Lawley TJ, Smith HR, Katz SI.
    Ann Intern Med; 1982 Aug 04; 97(2):165-70. PubMed ID: 7049027
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nodular vasculitis in systemic lupus erythematosus.
    Westers-Attema A, van Tubergen A, Plasschaert H, van Marion AM, Frank J, Poblete-Gutiérrez P.
    Int J Dermatol; 2008 Nov 04; 47 Suppl 1():3-6. PubMed ID: 18986475
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
    Highet AS.
    Br J Dermatol; 1980 Mar 04; 102(3):358-60. PubMed ID: 7370185
    [No Abstract] [Full Text] [Related]

  • 20. [Effectiveness of dapsone on refractory immune thrombocytopenia in a patient with systemic lupus erythematosus associated with sarcoidosis].
    Park YH, Sunamoto M, Miyoshi T, Konaka Y.
    Rinsho Ketsueki; 1993 Jul 04; 34(7):870-5. PubMed ID: 8360992
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.